Clinicopathological analysis of dementia disorders in the elderly - An update

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 61-70

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

Alzheimer disease; Clinico pathological correlations; Dementia disorders; Diagnostic accuracy rates

Indexed keywords

AGED; ALZHEIMER DISEASE; AUTOPSY; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SENILE DEMENTIA;

EID: 33744914744     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s308     Document Type: Review

References (62)

1. I. Alafuzoff, K. Iqbal, H. Friden, R. Adolfsson and B. Winblad, Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis, Acta Neuropathol (Berl) 74 (1987) 209-225.
2. H, Apaydin, J.E. Ahlskog, J.E. Parisi, B.F. Boeve and D.W. Dickson, Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response, Arch Neurol 59 (2002), 102-112.
3. J. Attems, F. Lintner and K.A. Jellinger, Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology, Acta Neuropathol (Berl) 107 (2004), 283-291.
4. C. Bancher, K. Jellinger, H. Lassmann, P. Fischer and F. Leblhuber, Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia, Eur Arch Psychiatry Clin Neurosci 246 (1996), 137-146.
5. L. Berg, D.W. McKeel Jr., J.P. Miller, J. Baty and J.C. Morris, Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older, Arch Neurol 50 (1993), 349-358.
6. L. Berg, D.W. McKeel Jr., J.P. Miller, M. Storandt, E.H. Rubin, J.C. Morris, J. Baty, M. Coats, J. Norton, A.M. Goate, J.L. Price, M. Gearing, S.S. Mirra and A.M. Saunders, Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype, Arch Neurol 55 (1998), 326-335.
7. F. Boller, O.L. Lopez and J. Moossy, Diagnosis of dementia: clinicopathologic correlations, Neurology 39 (1989), 76-79.
8. J.V. Bowler, D.G. Munoz, H. Merskey and V. Hachinski, Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease, J Neurol Neurosurg Psychiatry 64 (1998), 18-24.
9. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol (Berl) 82 (1991), 239-259.
10. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur and E. Braak, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging 24 (2003), 197-211.
11. H.C. Chui, J.I. Victoroff, D. Margolin, W. Jagust, R. Shankle, and R. Katzman, Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers, Neurology 42 (1992), 473-480.
12. E.J. Cochran, J.A. Schneider, D.A. Bennett et al., Application of NIA/Reagan Institute Working Group Criteria for diagnosis of Alzheimer's disease to members of the Religious Orders Study (abstr.), J Neuropathol Exp Neurol 57 (1998), 508.
13. D.G. Davis, F.A. Schmitt, D.R. Wekstein and W.R. Markesbery, Alzheimer neuropathologic alterations in aged cognitively normal subjects, J Neuropathol Exp Neurol 58 (1999), 376-388.
14. A. Delacourte, J.P. David, N. Sergeant, L. Buee, A. Wattez, P. Vermersch, F. Ghozali, C. Fallet-Bianco, F. Pasquier, F. Lebert, H. Petit and C. Di Menza, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease, Neurology 52 (1999), 1158-1165.
15. M. Emre, Dementia associated with Parkinson's disease, Lancet Neurol 2 (2003), 229-237.
16. M.S. Fernando and P.G. Ince, Vascular pathologies and cognition in a population-based cohort of elderly people, J Neurol Sci 226 (2004), 13-17.
17. F. Garcia-Sierra, J.J. Hauw, C. Duyckaerts, C.M. Wischik, J. Luna-Munoz and R. Mena, The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old, Acta Neuropathol (Berl) 100 (2000), 29-35.
18. M. Gearing, S.S. Mirra, J.C. Hedreen, S.M. Sumi, L.A. Hansen and A. Heyman, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part X: Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease, Neurology 45 (1995), 461-466.
19. H.J. Gertz, J. Xuereb, F. Huppert, C. Brayne, M.A. McGee, E. Paykel, C. Harrington, E. Mukaetova-Ladinska, T. Arendt and C.M. Wischik, Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease, Acta Neuropathol (Berl) 95 (1998), 154-158.
20. G. Gold, P. Giannakopoulos, C. Montes-Paixao Junior, F.R. Herrmann, R. Mulligan, J.P. Michel and C. Bouras, Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia, Neurology 49 (1997), 690-694.
21. G. Gold, C. Bouras, E. Kovari, A. Canuto, B.G. Glaria, A. Malky, P.R. Hof, J.P. Michel and P. Giannakopoulos, Clinical validity of Braak neuropathological staging in the oldest-old, Acta Neuropathol (Berl) 99 (2000), 579-582.
22. E. Gomez-Tortosa, I. Gonzalo, S. Fanjul, M.J. Sainz, S. Cantarero, C. Cemillan, J.G. Yebenes and T. del Ser, Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease, Arch Neurol 60 (2003), 1218-1222.
23. J. Gunstad and J. Browndyke, Understanding incidence and prevalence rates in mixed dementia, in: Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management, R.H. Paul, R. Cohen, B.R. Ott and S. Salloway, eds, Human Press Inc., Totowa, NJ, 2005, pp. 245-255.
24. A.J. Harding and G.M. Halliday, Simplified neuropathological diagnosis of dementia with Lewy bodies, Neuropathol Appl Neurobiol 24 (1998), 195-201.
25. A.J. Harding and G.M. Halliday, Cortical Lewy body pathology in the diagnosis of dementia, Acta Neuropathol (Berl) 102 (2001), 355-363.
26. V. Haroutunian, D.P. Perl, D.P. Purohit, D. Marin, K. Khan, M. Lantz, K.L. Davis and R.C. Mohs, Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease, Arch Neurol 55 (1998), 1185-1191.
27. B.T. Hyman and J.Q. Trojanowski, Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease, J Neuropathol Exp Neurol 56 (1997), 1095-1097.
28. P.G. Ince, F.K. McArthur, E. Bjertness, A. Torvik, J.M. Candy and J.A. Edwardson, Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions, Dementia 6 (1995), 162-168.
29. K. Jellinger, W. Danielczyk, P. Fischer and E. Gabriel, Clinicopathological analysis of dementia disorders in the elderly, J Neurol Sci 95 (1990), 239-258.
30. K.A. Jellinger, Clinical validity of Braak staging in the oldest-old, Acta Neuropathol 99 (2000), 583-584.
31. K.A. Jellinger, The pathology of ischemic-vascular dementia: an update, J Neurol Sci 203-204 (2002), 153-157.
32. K.A. Jellinger, Plaque-predominant and tangle-predominant variants of Alzheimer's disease, in: Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, D.W. Dickson, ed., ISN Neuropath Press, Basel, 2003, pp. 66-68.
33. K.A. Jellinger, Is Alzheimer's disease a vascular disorder? J Alzheimers Dis 5 (2003), 247-250; discussion 251-262.
34. K.A. Jellinger, Neuropathology of Alzheimer disease and clinical relevance, in: Alzheimer's Disease and Related Disorders: Research Advances, K. Iqbal and B. Winblad, eds, Ana Asian Intl. Acad. of Aging, Bucharest, Romania, 2003, pp. 152-169.
35. K.A. Jellinger and E. Mitter-Ferstl, The impact of cerebrovascular lesions in Alzheimer disease. A comparative autopsy study, J Neurol 250 (2003), 1050-1055.
36. K.A. Jellinger, The neuropathologic substrates of vascular-ischemic dementia, in: Current Clinical Neurology. Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management, R.H. Paul, R. Cohen, B.R. Ott and S. Salloway, eds, Humana Press, Totowa, NJ, 2005, pp. 23-57.
37. C.L. Joachim, J.H. Morris and D.J. Selkoe, Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases, Ann Neurol 24 (1988), 50-56.
38. D.S. Knopman, W.A. Rocca, R.H. Cha, S.D. Edland and E. Kokmen, Incidence of vascular dementia in Rochester, Minn, 1985-1989, Arch Neurol 59 (2002), 1605-1610.
39. D.S. Knopman, Alzheimer type dementia, in: Neurodegeneration. The Molecular Pathology of Dementia and Movement Disorders, D.W. Dickson, ed., ISN Neuropath Press, Basel, 2003, pp. 24-39.
40. A. Lim, D. Tsuang, W. Kukull, D. Nochlin, J. Leverenz, W. McCormick, J. Bowen, L. Teri, J. Thompson, E. R. Peskind, M. Raskind and E.B. Larson, Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series, J Am Geriatr Soc 47 (1999), 564-569.
41. W.R. Markesbery, Vascular dementia, in: Neuropathology of Dementing Disorders, W. Markesbery, ed., Arnold Publishers, London, 1998, pp. 293-311.
42. E.M. Martin, R.S. Wilson, R.D. Penn, J.H. Fox, R.A. Clasen and S.M. Savoy, Cortical biopsy results in Alzheimer's disease: correlation with cognitive deficits, Neurology 37 (1987), 1201-1204.
43. A.C. McKee, N.W Kowall, R. Au et al., Topography of neurofibrillary tangles distinguishes aging from Alzheimer disease (abstr.), J Neuropathol Exp Neurol 61 (2002), 488.
44. D.W. McKeel, J.L. Price, J.P. Miller, E.A. Grant, C. Xiong, L. Berg and J.C. Morris, Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type, J Neuropathol Exp Neurol 63 (2004), 1028-1037.
45. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, D.P. Salmon, J. Lowe, S.S. Mirra, E.J. Byrne, G. Lennox, N.P. Quinn, J.A. Edwardson, P.G. Ince, C. Bergeron, A. Burns, B.L. Miller, S. Lovestone, D. Collerton, E.N. Jansen, C. Ballard, R.A. de Vos, G.K. Wilcock, K.A. Jellinger and R.H. Perry, Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop, Neurology 47 (1996), 1113-1124.
46. I.G. McKeith, J. Mintzer, D. Aarsland, D. Burn, H. Chiu, J. Cohen-Mansfield, D. Dickson, B. Dubois, J.E. Duda, H. Feldman, S. Gauthier, G. Halliday, B. Lawlor, C. Lippa, O.L. Lopez, J. Carlos Machado, J. O'Brien, J. Playfer and W. Reid, Dementia with Lewy bodies, Lancet Neurol 3 (2004), 19-28.
47. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
48. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L. M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle and L. Berg, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology 41 (1991), 479-486.
49. J.T. Moroney, E. Bagiella, D.W. Desmond, V.C. Hachinski, P.K. Molsa, L. Gustafson, A. Brun, P. Fischer, T. Erkinjuntti, W. Rosen, M.C. Paik and T.K. Tatemichi, Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias, Neurology 49 (1997), 1096-1105.
50. J.C. Morris, D.W. McKeel Jr., K. Fulling, R.M. Torack and L. Berg, Validation of clinical diagnostic criteria for Alzheimer's disease, Ann Neurol 24 (1988), 17-22.
51. D.G. Munoz, D.W. Dickson, C. Bergeron, I.R. Mackenzie, A. Delacourte and V. Zhukareva, The neuropathology and biochemistry of frontotemporal dementia, Ann Neurol 54(Suppl 5) (2003), S24-S28.
52. Neuropathology-Group, Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS), Lancet 357 (2001), 169-175.
53. K.L. Newell, B.T. Hyman, J.H. Growdon and E.T. Hedley-Whyte, Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease, J Neuropathol Exp Neurol 58 (1999), 1147-1155.
54. H. Petrovitch, L.R. White, G.W. Ross, S.C. Steinhorn, C.Y. Li, K.H. Masaki, D.G. Davis, J. Nelson, J. Hardman, J.D. Curb, P.L. Blanchette, L.J. Launer, K. Yano and W.R. Markesbery, Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study, Neurology 57 (2001), 226-234.
55. K.P. Riley, D.A. Snowdon and W.R. Markesbery, Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study, Ann Neurol 51 (2002), 567-577.
56. W.A. Rocca and D.S. Knopman, Prevalence and incidence patterns of vascular dementia, in: Vascular Cognitive Impairment. Preventable Dementia, in: J.V. Bowler and V. Hachinski, eds, Oxford Univ. Press, Oxford, 2003, pp. 21-32.
57. G.C. Román, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, J.H. Garcia, L. Amaducci, J.M. Orgogozo, A. Brun, A. Hofman et al., Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology 43 (1993), 250-260.
58. R. Sulkava, T. Erkinjuntti, M. Haltia, A. Paetau, J. Palo and J. Wikström, Non-Alzheimer dementias fulfilling the NINCDS-ADRDA criteria for probable Alzheimer's disease, in: Aging of the Brain and Dementia: Ten Years later, L. Amaducci, ed., Abstract Book, Florence, 1989, pp. 125.
59. J.Q. Trojanowski and D. Dickson, Update on the neuropathological diagnosis of frontotemporal dementias, J Neuropathol Exp Neurol 60 (2001), 1123-1126.
60. J.P. Wade, T.R. Mirsen, V.C. Hachinski, M. Fisman, C. Lau and H. Merskey, The clinical diagnosis of Alzheimer's disease, Arch Neurol 44 (1987), 24-29.
61. B. Winblad, W. Wallace, J. Hardy, C. Fowler, G. Bucht, I. Alafuzoff and R. Adolfson, Neurochemical, genetic and clinical aspects of Alzheimer's disease, in: Dimensions in Aging, M. Bergener, M. Ermini and H.B. Stähelin, eds, Academic Press, London, 1986, pp. 183-203.
62. D. Zekry, C. Duyckaerts, J. Belmin, C. Geoffre, F. Herrmann, R. Moulias and J.J. Hauw, The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy, Neurobiol Aging 24 (2003), 213-219.